Analytical Data
-
基因名
D8L
- Application
-
别名
D8L；Putative ATP-dependent RNA helicase DDX11-like Protein 8
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
L7QJR5
-
表达区间
1-261aa
-
氨基酸序列
MPQQLSPINIETKKAISNARLKPLDIHYNESKPTTIQNTGKLVRINFKGGYISGGFLPNEYVLSSLRIYWGKEDDYGSNHLIDVYKYSGEINLVHWNKKKYSSYEEAKKHDDGLIIISIFLQVSDHKNVYFQKIVNQLDSIRSANTSAPFDSVFYLDNLLPSTLDYFTYLGTTINHSADAAWIIFPTPINIHSDQLSKFRTLLSSSNHDGKPHYITENYRNPYKLNDDTQVYYSGEIIRAATTSPARDNYFMRWLSDLRET
-
分子量
37.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of D8L recombinant protein is rooted in the quest to understand viral mechanisms and develop effective vaccines. D8L is a protein found in certain viruses, particularly within the family of Poxviridae, where it plays a crucial role in the virus's ability to evade the host immune response. By analyzing its structure and function, researchers aim to unravel the molecular interactions that D8L engages in during viral replication and immune evasion. Understanding these processes can pave the way for innovative therapeutic strategies and vaccine development, particularly in combating viral infections that have significant public health implications. Moreover, the recombinant expression of D8L in laboratory settings enables detailed studies of its properties, the characterization of its antigenicity, and its potential use as a target for vaccine creation. Such research not only enhances our fundamental understanding of virology but also contributes to broader efforts in infectious disease control and vaccine efficacy.
